跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pradaxa 110 mg, hard capsules - HSA Drug Approval Details
Approvals
/
HSA
/
Pradaxa 110 mg, hard capsules
Approved
STANDARD
Pradaxa 110 mg, hard capsules
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
f03931257b850c6c
Company
Unknown
Type
Standard
Approval Details
Approval Id
f03931257b850c6c
Drug Name
Pradaxa 110 mg, hard capsules
Active Ingredients
DABIGATRAN ETEXILATE MESILATE 126.83 mg EQV DABIGATRAN ETEXILATE
110 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
f03931257b850c6c
Type
Standard
Back to HSA Approvals